The higher discontinuation
rate in the dapagliflozin group compared with the glipizide
group (as a result of an AE, 13.3 vs 11.3%) was attributed
to more discontinuations because of decreased renal creatinine
clearance compared with the glipizide group [16 vs 10 patients
(Table 3)]